A Mobile Health-enabled Lifestyle Intervention Among Women With History of Gestational Diabetes(GDM)
Reverse-DM
A Mobile Health (mHealth)-Enabled Lifestyle Intervention Among Women With History of Gestational Diabetes (GDM): a Pilot Randomized Controlled Trial
1 other identifier
interventional
61
1 country
1
Brief Summary
This study aims to explore: (1) the relationship between lifestyle factors (eating, movement behaviour, sleep and stress) and glycaemic profile, and (2) the feasibility of delivering lifestyle intervention through the proposed mHealth strategy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 25, 2022
CompletedFirst Posted
Study publicly available on registry
August 23, 2022
CompletedStudy Start
First participant enrolled
September 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 28, 2023
CompletedNovember 8, 2023
November 1, 2023
7 months
July 25, 2022
November 7, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mobile health application feasibility
Number of participants that show a change in lifestyle behaviour through the mobile health application usage.
10 weeks
Secondary Outcomes (8)
Oral glucose tolerance test (OGTT) measurements
Week -1 and 10
Change in sleep quality as assessed by the Oura Ring Sleep Score.
10 weeks
Change in daily physical activity levels as assessed by the Oura Ring Activity Score.
10 weeks
Postprandial glucose
14 days
Change in quality of life
Week -1 and 10
- +3 more secondary outcomes
Study Arms (2)
Group 1 (Intervention group)
EXPERIMENTALGroup 1 (Intervention group) :Oura ring with Oura App + HealthifySG App (receive lifestyle interventions via HealthifySG App)
Group 2 (Control group)
OTHERGroup 2 (Control group) : Oura ring with Oura App alone (without lifestyle interventions)
Interventions
The study aim to conduct lifestyle intervention trials to examine the feasibility, efficacy, and cost-effectiveness of the mHealth approach in preventing them from developing Type 2 Diabetes in the future. This pilot study will primarily aim to determine the feasibility of our intervention approaches as well as enhance health literacy and promote healthy lifestyle in the study participants. In the longer term, we hope that the proposed mHealth intervention can be translated to include women from the community setting and involve wider healthcare setting to come together and reduce the burden of Type 2 Diabetes in Singapore.
Eligibility Criteria
You may qualify if:
- Healthy female volunteers (age 21-45 years)
- A history of GDM in the past 5 years
- Not planning to conceive during the study period
- Not performing full breastfeeding during the study period
- Own a smart phone(mobile phone) compatible with study App (Android v10 and above)
- Proficient in English language
- Plan to stay in Singapore for the next 1 year
- Willing to comply to study protocol
- Able to provide a written informed consent
You may not qualify if:
- Current and/or previous diagnosis of diabetes except GDM
- Currently pregnant
- Given birth within last 12 weeks
- Following special diet or dietary restriction
- Experiencing severely limited mobility (e.g. wheelchair bound, need walking aid etc.)
- Diagnosed with malnutrition, eating disorder, severe insomnia
- Diagnosed with cancers, unstable heart related diseases, severe kidney disease
- Diagnosed with severe unstable mental conditions, dementia or cognitive impairment
- Alcohol or drug abuse
- Medications known to influence glucose metabolism e.g. peroral corticosteroids
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Human Development Research Centre (Hdrc)
Singapore, 117597, Singapore
Related Publications (1)
Liew SJ, Soon CS, Chooi YC, Tint MT, Eriksson JG. A holistic approach to preventing type 2 diabetes in Asian women with a history of gestational diabetes mellitus: a feasibility study and pilot randomized controlled trial. Front Clin Diabetes Healthc. 2023 Sep 28;4:1251411. doi: 10.3389/fcdhc.2023.1251411. eCollection 2023.
PMID: 37841647DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- 60-80 female subjects will be randomized to either Group 1 (Intervention group) or Group 2 (Control group) based on 1:1 allocation. HealthifySG App will only be installed on the phones of subjects for Group 1(Intervention group).
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Executive Director & Programme Director (Human Development)
Study Record Dates
First Submitted
July 25, 2022
First Posted
August 23, 2022
Study Start
September 19, 2022
Primary Completion
April 28, 2023
Study Completion
April 28, 2023
Last Updated
November 8, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share